Clinical Trials Logo

Food Hypersensitivity clinical trials

View clinical trials related to Food Hypersensitivity.

Filter by:

NCT ID: NCT04400214 Completed - Child, Only Clinical Trials

The Food Allergy Superheroes Training (FAST) Program

FAST Program
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

Among children with a food allergy, strict avoidance (e.g., elimination of allergenic foods from one's diet) is the only intervention capable of preventing potentially devastating health-related sequelae including anaphylaxis and death. Youths from low-income backgrounds are particularly impacted by food allergies and may be the population most apt to benefit from a brief, portable, and engaging skills-based intervention designed to teach young children the skills needed to remain adherent to food allergy safety guidelines. Data collected as part of the proposed project will lay the groundwork for a line of federally-funded intervention research broadly examining how to promote adherence to food allergy safety guidelines among young children from low-income backgrounds through implementation of a robust, efficient, and portable intervention.

NCT ID: NCT04378335 Completed - Clinical trials for Food Allergy in Children

Assessment of Orality Disorders in Children With Food Allergies

ALLERGORAL
Start date: October 21, 2020
Phase: N/A
Study type: Interventional

Orality disorders are frequent in child. There are complications like growth and psychomotor development disorders. The aim is to estimate the prevalence of orality disorder for child with one or several food allergy.

NCT ID: NCT04376242 Recruiting - Food Allergy Clinical Trials

Virtual Reality Technology Versus Standard Technology During Pediatric Oral Food Challenge

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if non-invasive distracting devices (Virtual Reality headset) are more effective than the standard of care of utilizing existing technologies that are currently more common in food allergy research treatment and clinics (i.e. television and patients' personal electronic devices) for decreasing levels anxiety and fear in pediatric patients undergoing oral food challenge (OFC) and their caregivers.

NCT ID: NCT04345185 Completed - Obesity Clinical Trials

Effects of Infant Egg Consumption on Child Health and Cognition Development

Start date: January 1, 1999
Phase:
Study type: Observational

The objective of this study is to examine how infant egg consumption (age of introduction and frequency of intake) influences physical growth, obesity, cardio-metabolic health, risk of food allergy, and cognition development in mid-childhood and adolescence.

NCT ID: NCT04329078 Not yet recruiting - Allergy;Food Clinical Trials

Relevance of Sensitization to Legumes in Children Allergic to Peanut

Start date: April 1, 2020
Phase:
Study type: Observational

The objectives of this study are to determine in children allergic to peanut (i) the prevalence of sensitization to other legumes, (ii) the prevalence of allergy to each legume in patients who are sensitized to it (iii ) the severity of the allergy to legumes other than peanut

NCT ID: NCT04312438 Recruiting - Food Allergy Clinical Trials

Safety of Oral Food Challenge With Cow's Milk Proteins in Children With Food Allergy

Start date: June 2020
Phase: N/A
Study type: Interventional

The aim of the study is to assess the safety of an oral food challenge (OFC) with cow's milk proteins and to assess the tolerance of cow's milk proteins in children with a food allergy after introducing cow's milk into the diet.

NCT ID: NCT04262648 Completed - Constipation Clinical Trials

Randomized Placebo-controlled Study of L. Reuteri NCIMB 30351 in GI Functional Disorders and Food Allergy in Newborns

Start date: March 3, 2020
Phase: N/A
Study type: Interventional

This study is a randomized, placebo-controlled, single-masked (blinded), post-marketing clinical study of a drug Lactobacillus Reuteri NCIMB 30351 drops in functional disorders of gastrointestinal tract and skin symptoms of food allergies in children between the ages of one and four months inclusive. The aim of the study is to assess clinical effects of probiotics Lactobacillus Reuteri NCIMB 30351 drops on the symptoms of infantile colic, constipation, diarrhea, gastroesophageal reflux, atopic dermatitis/eczema in full-term newborns during the first months of life, laboratory parameters of microbiome will also be assessed. A prospective study comparing two treatment groups: Group 1 (treatment group) - 60 infants. Group 2 (control group) - 30 infants, placebo. The study drug will be taken in 1 time per day within 25 days. Allowed symptomatic therapy includes defoamers (simethicone-based preparations), carminative preparations (dill water (fennel)), etc.

NCT ID: NCT04249973 Active, not recruiting - Food Allergy Clinical Trials

Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children

Start date: January 26, 2018
Phase:
Study type: Observational [Patient Registry]

In this study, fecal and urine samples will be collected from children diagnosed with : - IgE mediated cow's milk allergy, - suspected of a cow's milk allergy, but with negative diagnosis - IgE mediated food allergy other than cow's milk - healthy brothers and sisters of the first three groups A subset of patients with IgE-mediated cow's milk allergy will be asked to provide a urine and fecal sample yearly for prognostic purposes. The samples will be analyzed using a technique called metabolomics to identify biomarker candidates with diagnostic and/or prognostic potential. Additionally, microbiome analysis will be performed to map the microbiome of all groups.

NCT ID: NCT04239131 Recruiting - Clinical trials for Hypersensitivity, Food

Prospective Study About Sensitization Pattern to Insects as Food Source in Patients With House Dust Mite Allergy

InFood
Start date: March 15, 2021
Phase: N/A
Study type: Interventional

Patients allergic to seafood and/or sensitized to Tropomyosin of Skin Prick tests SPT or crustacean origin will may be also be sensitized to edible insects. Aim of the study is to evaluate whether patients allergic to seafood and/or sensitized to Tropomyosin of SPT or crustacean origin may be more often be sensitized to edible insects used as food source.

NCT ID: NCT04200989 Withdrawn - Food Allergy Peanut Clinical Trials

Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy

Start date: March 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Use of three intralymphatic injections of peanut allergen one month apart to induce tolerance to peanut in peanut allergic people.